Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
HUMAW | US
0.10
5.55%
Healthcare
Biotechnology
30/06/2024
21/10/2024
1.90
1.87
1.90
1.75
Humacyte Inc. a clinical-stage biotechnology platform company develops and manufactures off-the-shelf bioengineered human tissues. The company develops and manufactures acellular tissues to address life- and limb-threatening vascular conditions for complex organ disease. Its Human Acellular Vessel (HAV) a regenerative vascular conduit that is in late-stage clinical trials targeting multiple vascular applications including vascular trauma repair arteriovenous access for hemodialysis and peripheral arterial disease. The company was founded in 2004 and is based in Durham North Carolina.
View LessStrength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
170.9%1 month
147.5%3 months
120.7%6 months
155.5%-
-
-
-0.63
0.13
-
-
-
-99.65M
-
-
-
-
-
248.50
-850.81
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.98
Range1M
0.98
Range3M
2.16
Rel. volume
1.10
Price X volume
57.44K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
OCEAW | OCEAW | Biotechnology | 0.0398 | 0 | 2.58% | n/a | -16.02% |
Nutriband Inc. Warrant | NTRBW | Biotechnology | 1.15 | 0 | 9.52% | n/a | 1.72% |
NKGen Biotech Inc. Warrants | NKGNW | Biotechnology | 0.032 | 0 | 29.03% | n/a | -40.33% |
JSPRW | JSPRW | Biotechnology | 0.21 | 0 | 0.00% | n/a | 2.31% |
ICUCW | ICUCW | Biotechnology | 0.039 | 0 | 0.52% | n/a | -45.50% |
EyeGate Pharmaceuticals Inc | EYEG | Biotechnology | 36.05 | 0 | -0.92% | n/a | |
COEPW | COEPW | Biotechnology | 0.034 | 0 | 70.85% | n/a | 25.11% |
CELUW | CELUW | Biotechnology | 0.0188 | 0 | 27.03% | n/a | 127.38% |
XOMAP | XOMAP | Biotechnology | 26.24 | 0 | -0.23% | 26.27 | 121.93% |
XOMA Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock | XOMAO | Biotechnology | 25.5992 | 0 | 0.02% | 25.57 | 121.93% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
No data |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | - | 0.53 | - |
Ent. to Revenue | - | 3,967.00 | - |
PE Ratio | - | 41.03 | - |
Price to Book | - | 15.55 | - |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 120.72 | 72.80 | Riskier |
Debt to Equity | -0.63 | -1.23 | Expensive |
Debt to Assets | 0.13 | 0.25 | Cheaper |
Market Cap | - | 3.66B | - |